Venus Concept (NASDAQ:VERO) Announces Earnings Results

Venus Concept (NASDAQ:VERO) posted its quarterly earnings results on Monday. The company reported ($11.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($10.01) by ($1.22), RTT News reports. The company had revenue of $15.77 million for the quarter, compared to analysts’ expectations of $16.99 million. Venus Concept updated its Q1 2025 guidance to EPS.

Venus Concept Stock Up 1.5 %

Shares of NASDAQ:VERO opened at $2.79 on Tuesday. Venus Concept has a one year low of $2.33 and a one year high of $17.49. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18. The stock has a market cap of $1.84 million, a price-to-earnings ratio of -0.35 and a beta of 0.52. The company has a 50 day moving average of $3.43 and a 200-day moving average of $4.20.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.